Janus Henderson Group plc 13D and 13G filings for Cardiff Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 09:23 am Sale |
2022-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
JANUS HENDERSON GROUP PLC JHG |
0 0.000% |
-3,523,012 (Position Closed) |
Filing |
| 2022-02-10 2:25 pm Purchase |
2021-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
JANUS HENDERSON GROUP PLC JHG |
3,523,012 8.400% |
1,385,341 (+64.81%) |
Filing |
| 2021-02-12 3:06 pm Purchase |
2020-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
JANUS HENDERSON GROUP PLC JHG |
2,137,671 6.100% |
2,137,671 (New Position) |
Filing |